http://hdl.handle.net/1765/27657
http://dx.doi.org/10.1093/jnci/djp524
pubmed: 20229619
scopus: 77749279752
http://dx.doi.org/10.1093/jnci/djp524
pubmed: 20229619
scopus: 77749279752
Response Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
March 2010
Article
volume 102, issue 5 pp 359-360.
(Free full text at PubMed)
Repository contains one file which is not publicly available